Asoprisnil

DB06680InvestigationalSmall molecule

Asoprisnil (J867) is a selective progesterone receptor modulator. It can be used to treat progesterone sensitive myomata.

Mechanism: Pharmacologically active on Progesterone receptor
Curator reviewed
Primary indication: Investigated for use/treatment in uterine fibroids.Curator reviewed
Formula / weight: C₂₈H₃₅NO₄ · 449.5818 g/mol (avg)
Code names: BAY86-5294 · J-867

Resolves to

Compound

UNII72W09924WPCAS199396-76-4ChEMBLCHEMBL267431

Structure

InChIKeyGJMNAFGEUJBOCE-MEQIQULJSA-NSMILES[H]\C(=N/O)C1=CC=C(C=C1)[C@@]1([H])C[C@@]2(C)[C@@]([H])(CC[C@]2(COC)OC)[C@]2([H])CCC3=CC(=O)CCC3=C12

Targets

P06401PGR

What you can answer from here — as of August 26, 2024

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Asoprisnil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account